Alkermes

Alkermes is a global biopharmaceutical company that specializes in developing innovative medicines for central nervous system (CNS) diseases and oncology. They generate revenue through the research, development, and commercialization of pharmaceutical products, including proprietary drugs and collaborations with other pharmaceutical companies. Founded in 1987, Alkermes has a rich history of scientific innovation and has developed several FDA-approved therapies. The company is headquartered in Dublin, Ireland, with a significant operational presence in the United States.

Recent Posts by Alkermes

1-20 of 786